Deborah Crouch

Array ( [id] => 8759874 [patent_doc_number] => 08420393 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-16 [patent_title] => 'Generation of an autologous stem cell library from human oocytes parthenogenetically activated by high or low oxygen tension' [patent_app_type] => utility [patent_app_number] => 13/352252 [patent_app_country] => US [patent_app_date] => 2012-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 17 [patent_no_of_words] => 47842 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 179 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13352252 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8251865 [patent_doc_number] => 20120156192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-21 [patent_title] => 'Treatment of Diseases and Disorders Using Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro' [patent_app_type] => utility [patent_app_number] => 13/349394 [patent_app_country] => US [patent_app_date] => 2012-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 40150 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20120156192.pdf [firstpage_image] =>[orig_patent_app_number] => 13349394 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8239817 [patent_doc_number] => 20120148544 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-14 [patent_title] => 'Treatment of Diseases and Disorders Using Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro' [patent_app_type] => utility [patent_app_number] => 13/349385 [patent_app_country] => US [patent_app_date] => 2012-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 40169 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13349385 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8172451 [patent_doc_number] => 20120107927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'METHODS AND DEVICES FOR ISOLATING EMBRYONIC STEM CELLS' [patent_app_type] => utility [patent_app_number] => 13/341364 [patent_app_country] => US [patent_app_date] => 2011-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6225 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20120107927.pdf [firstpage_image] =>[orig_patent_app_number] => 13341364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8158582 [patent_doc_number] => 20120100215 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-26 [patent_title] => 'MULLER STEM CELLS' [patent_app_type] => utility [patent_app_number] => 13/341042 [patent_app_country] => US [patent_app_date] => 2011-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 3996 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20120100215.pdf [firstpage_image] =>[orig_patent_app_number] => 13341042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9869098 [patent_doc_number] => 08956868 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-17 [patent_title] => 'Induced pluripotent stem cells produced with a connexin inhibitor and a TGF-β signaling inhibitor' [patent_app_type] => utility [patent_app_number] => 13/337767 [patent_app_country] => US [patent_app_date] => 2011-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 9255 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13337767 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9153451 [patent_doc_number] => 08586358 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-19 [patent_title] => 'HLA homozygous cells' [patent_app_type] => utility [patent_app_number] => 13/333010 [patent_app_country] => US [patent_app_date] => 2011-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 13851 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13333010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8291815 [patent_doc_number] => 20120180143 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-12 [patent_title] => 'TRANSGENIC ANIMAL MODEL OF NEURODEGENERATIVE DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/332810 [patent_app_country] => US [patent_app_date] => 2011-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10312 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13332810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9413012 [patent_doc_number] => 08697048 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-15 [patent_title] => 'Peptide amphiphile suspension to prevent or reduce tumor formation from administered embryonic stem cells' [patent_app_type] => utility [patent_app_number] => 13/333348 [patent_app_country] => US [patent_app_date] => 2011-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3525 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13333348 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8172478 [patent_doc_number] => 20120107934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'Human Late Stage Motor Neuron Progenitor Cells and Methods of Making and Using Same' [patent_app_type] => utility [patent_app_number] => 13/324956 [patent_app_country] => US [patent_app_date] => 2011-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14765 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20120107934.pdf [firstpage_image] =>[orig_patent_app_number] => 13324956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9299647 [patent_doc_number] => 08647872 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-11 [patent_title] => 'Human embryonic stem cell line prepared by nuclear transfer of a human somatic cell into an enucleated human oocyte' [patent_app_type] => utility [patent_app_number] => 13/316199 [patent_app_country] => US [patent_app_date] => 2011-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10316 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13316199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8780793 [patent_doc_number] => 20130102768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-25 [patent_title] => 'EFFICIENT METHOD FOR NUCLEAR REPROGRAMMING' [patent_app_type] => utility [patent_app_number] => 13/313670 [patent_app_country] => US [patent_app_date] => 2011-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12983 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13313670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8196936 [patent_doc_number] => 20120121549 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'INDUCED PLURIPOTENT STEM CELLS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 13/292014 [patent_app_country] => US [patent_app_date] => 2011-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12972 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20120121549.pdf [firstpage_image] =>[orig_patent_app_number] => 13292014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8927997 [patent_doc_number] => 20130183757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-18 [patent_title] => 'METHOD OF EFFICIENTLY ESTABLISHING INDUCED PLURIPOTENT STEM CELLS' [patent_app_type] => utility [patent_app_number] => 13/824087 [patent_app_country] => US [patent_app_date] => 2011-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11588 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13824087 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8159245 [patent_doc_number] => 20120100615 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-26 [patent_title] => 'CELL FATE CONVERSION OF DIFFERENTIATED SOMATIC CELLS INTO GLIAL CELLS' [patent_app_type] => utility [patent_app_number] => 13/280562 [patent_app_country] => US [patent_app_date] => 2011-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11882 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20120100615.pdf [firstpage_image] =>[orig_patent_app_number] => 13280562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7731487 [patent_doc_number] => 20120014931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'HUMAN LATE STAGE MOTOR NEURON PROGENITOR CELLS' [patent_app_type] => utility [patent_app_number] => 13/243064 [patent_app_country] => US [patent_app_date] => 2011-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14765 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20120014931.pdf [firstpage_image] =>[orig_patent_app_number] => 13243064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7719825 [patent_doc_number] => 20120009160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'CELLS FOR THE TREATMENT OF NERVOUS SYSTEM DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/233701 [patent_app_country] => US [patent_app_date] => 2011-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 13427 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20120009160.pdf [firstpage_image] =>[orig_patent_app_number] => 13233701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10870109 [patent_doc_number] => 08895302 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-25 [patent_title] => 'Directed differentiation of primate pluripotent stem cells into functional basal forebrain cholinergic neurons (BFCNs) and medium spiny gabaergic projection neurons' [patent_app_type] => utility [patent_app_number] => 13/207202 [patent_app_country] => US [patent_app_date] => 2011-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 9 [patent_no_of_words] => 12022 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13207202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7807608 [patent_doc_number] => 20120058562 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-08 [patent_title] => 'REPROGRAMMING IMMORTALIZED B CELLS' [patent_app_type] => utility [patent_app_number] => 13/197529 [patent_app_country] => US [patent_app_date] => 2011-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 35391 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20120058562.pdf [firstpage_image] =>[orig_patent_app_number] => 13197529 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7720266 [patent_doc_number] => 20120009601 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'METHODS AND COMPOSITIONS FOR REPROGRAMMING CELLS' [patent_app_type] => utility [patent_app_number] => 13/177662 [patent_app_country] => US [patent_app_date] => 2011-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 30687 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20120009601.pdf [firstpage_image] =>[orig_patent_app_number] => 13177662 [rel_patent_id] =>[rel_patent_doc_number] =>)